EJ [E-HOUSE (CHINA)] 6-K: E-House Reports Fourth Quarter and Full Year 2012

[E-House Reports Fourth Quarter and Full Year 2012 Results and Declares Cash Dividend SHANGHAI, China, March 12, 2013 — E-House (China) Holdings Limited (“E-House” or the “Company”) (NYSE: EJ), a leading real estate services company in China, today announced its unaudited financial results for the fiscal quarter and full year ended December 31, 2012, and declared a cash dividend of] [E-HOUSE (CHINA) HOLDINGS LIMITED 17/F, East Tower No. 333 North Chengdu Road Shanghai 200041 People’s Republic of China Form 20-F x Form 40-F o o o E-House (China) Holdings Limited Bin Laurence]

CBPO [China Biologic Products] 8-K: (Original Filing)

[China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2012 FY12 Total Sales Up 20.7% to $184.8 Million FY12 Operating Margin Reaching 40.3% FY12 Non-GAAP Net Income Up 31.5% to $48.0 Million BEIJING, March 13, 2013 /PRNewswire-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): November 8, 2012 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6698-3166 (Former name or former address,]

Skip to toolbar